In the News

Read our key takeaways from the second half of the American Association for Cancer Research’s 2019 annual meeting.

Results from the first phase I clinical trial of a new drug were presented at the American Association for Cancer Research’s meeting.

Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.

Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.

Researchers discover that a curious type of cell death plays a role in normal development.

Thousands of oncology experts from around the world will gather in Atlanta from March 29 – April 3 for the American Association for Cancer Research (AACR) Annual Meeting 2019. Memorial Sloan Kettering experts are involved in notable research presented at the meeting and are available to comment on topics including immunotherapy, precision medicine and targeted treatments, genomics, cancer interception and prevention, clinical trial design, cancer health disparities, and more. For more information and to set up interviews or access photos and video, contact [email protected] and [email protected].

Researchers have redesigned CAR T cells in hopes of improving immunotherapy treatment for multiple myeloma.

Learn more about world-class cancer care on Long Island at MSK Nassau.

A drug already approved for anemia offers hope for people with acute myeloid leukemia.

Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions.